GlaxoSmithKline Financial Market Data
| Last Close 19-Sep-2008 |
$44.52 |
Price/ Sales Ratio |
0.42 |
| 52-Week High |
$54.64 |
Price/ Book Ratio |
0.99 |
| 52-Week Low |
$40.51 |
Price/ Earnings Ratio |
23.56 |
| 60-Month Beta |
0.3 |
Price/ Cash Flow Ratio |
1.54 |
| Market Cap (mil.) |
-- |
Return on Assets |
12.6% |
| Shares Outstanding (mil.) |
-- |
Return on Equity |
24.4% |
| Dividend Rate |
2.20 |
Current Ratio |
1.32 |
| Dividend Yield |
220.0% |
Long-Term Debt/Equity |
1.13 |
| # of Institutional Holders |
582 |
% Owned by Institutions |
13.0% |
| Latest Short Interest Ratio |
6.04 |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
0.7% |
16.8% |
34.6% |
| EPS Growth |
3,050.0% |
8.6% |
0.0% |
| Dividend Growth |
11.1% |
42.9% |
73.5% |
This data is provided as per license from EDGAR Online
